文献速递妇产科病理细胞病理与分子病理

卵巢囊肿液细针穿刺细胞学检查的性能评估

Performance of ovarian cyst fluid fine-needle aspiration cytology.
PubMed 文献 · Cancer Cytopathol · 2017-08-21

该研究回顾1998至2016年459例卵巢囊肿液细针穿刺(FNA)细胞学标本,以手术病理为金标准计算诊断性能。结果示良性、非典型、可疑、恶性FNA分别为416例(90.6%)、32例(7.0%)、4例(0.9%)、7例(1.5%);灵敏度和特异度分别为54.0%和100%,阳性预测值1.00,阴性预测值0.97。结论认为卵巢囊肿液细胞学对恶性肿瘤检测高度特异、中度敏感,阴性结果在低验前概率患者中可令人安心。

要点

  • 卵巢囊肿液FNA细胞学诊断恶性特异度100%,灵敏度54.0%。
  • 可疑和恶性FNA随访恶性率均为100%(5/5和7/7)。
  • 良性FNA随访恶性率3.8%(10/264),阴性预测值0.97。

核心结论

  • 卵巢囊肿液细胞学对卵巢恶性肿瘤检测高度特异(100%)且中度敏感(54.0%)。
  • 阴性FNA结果在低验前概率恶性肿瘤患者中具有 reassuring 价值。

研究设计与样本

  • 回顾性研究,检索1998至2016年电子数据库卵巢囊肿液细胞学标本。
  • 共纳入459例卵巢囊肿FNA标本,其中300例(65.4%)有对应手术病理。
  • 以手术病理诊断为金标准计算测试性能。

主要发现

  • 459例FNA诊断分布:良性416例(90.6%)、非典型32例(7.0%)、可疑4例(0.9%)、恶性7例(1.5%)。
  • 随访恶性率(含交界性肿瘤):良性FNA 10/264(3.8%)、非典型0/24(0%)、可疑5/5(100%)、恶性7/7(100%)。
  • 测试灵敏度54.0%,特异度100%,阳性预测值1.00,阴性预测值0.97,疾病(恶性)患病率7.33%。

关键数值与推荐

  • 良性FNA随访恶性率3.8%(10/264),非典型FNA为0%(0/24)。
  • 可疑FNA随访恶性率100%(5/5),恶性FNA为100%(7/7)。
  • 灵敏度54.0%,特异度100%,阳性预测值1.00,阴性预测值0.97。
  • 疾病(恶性)患病率7.33%。

临床怎么用

  • 卵巢囊肿液FNA细胞学高度特异,可用于支持恶性诊断。
  • 阴性FNA在低验前概率患者中可提供 reassuring 信息。
  • 中度敏感提示阴性结果不能完全排除恶性,需结合临床和影像。

局限性

  • 仅65.4%(300/459)的FNA标本有对应手术病理,可能存在随访偏倚。
  • 研究为单中心回顾性设计,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although ovarian fine-needle aspiration (FNA) cytology is not commonly used as a primary modality of diagnosis for patients with ovarian lesions, many ovarian cysts are aspirated intraoperatively and occasionally for diagnostic purposes. Therefore, the ability to interpret these specimens remains critical. Previous studies have suggested a high specificity but low sensitivity as a limitation. The objective of the current study was to further explore the use and performance of ovarian cyst FNA for diagnosing malignancy at the study institution. METHODS: The electronic database was searched from 1998 through 2016 for ovarian cyst fluid cytology specimens; any concurrent or follow-up surgical pathology; and clinical information including patient age, radiology findings, and procedure type. Test performance was calculated using the surgical pathology diagnosis as the gold standard. RESULTS: A total of 459 ovarian cyst FNA specimens had the following diagnoses: 416 (90.6%) were diagnosed as benign, 32 (7.0%) as atypical, 4 (0.9%) as suspicious, and 7 (1.5%) as malignant. Overall, 300 specimens (65.4%) had a corresponding surgical pathology specimen. On follow-up, the rate of malignancy (including borderline neoplasms) for benign FNA was 10 of 264 specimens (3.8%), that for atypical FNA was 0 of 24 specimens (0%), that for suspicious FNA was 5 of 5 specimens (100%), and that for malignant FNA was 7 of 7 specimens (100%). Test sensitivity was 54.0% and test specificity was 100%. The positive predictive value was 1.00 and the negative predictive value was 0.97, with a disease (malignancy) prevalence of 7.33%. CONCLUSIONS: Ovarian cyst fluid cytology is highly specific and moderately sensitive for the detection of ovarian malignancies. A negative FNA is reassuring for patients with a low pretest probability of malignancy. Cancer Cytopathol 2018;126:112-21. © 2017 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Zhou AG, Levinson KL, Rosenthal DL, et al. Performance of ovarian cyst fluid fine-needle aspiration cytology. Cancer Cytopathol. 2017. PMID: 28834408. doi:10.1002/cncy.21911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。